Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

ClinicalTrials.gov ID: NCT06290128

Public ClinicalTrials.gov record NCT06290128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 9:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Placebo-controlled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate efficacy of riliprubart compared to placebo in adult participants with CIDP whose disease is refractory to standard of care. The study duration will be for a maximum of 111 weeks including screening, treatment phases, and follow-up.

Study identification

NCT ID
NCT06290128
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
109 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2024
Primary completion
Jun 9, 2026
Completion
Oct 30, 2027
Last update posted
Aug 9, 2026

2024 – 2027

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Alabama Neurology Associates- Site Number : 8400019 Homewood Alabama 35209
USC Norris Comprehensive Cancer Center- Site Number : 8400002 Los Angeles California 90033
University of California Irvine - Manchester Pavilion- Site Number : 8400007 Orange California 92868
IMMUNOe International Research Centers - Centennial- Site Number : 8400049 Centennial Colorado 80112
Yale University School of Medicine- Site Number : 8400018 New Haven Connecticut 06510
Nova Clinical Research - Bradenton- Site Number : 8400044 Bradenton Florida 34209
Design Neuroscience Center- Site Number : 8400053 Miami Lakes Florida 33016
NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024 Glenview Illinois 60026
University of Kansas Medical Center- Site Number : 8400010 Kansas City Kansas 66160
NeuroMedical Clinic of Central Louisiana- Site Number : 8400031 Alexandria Louisiana 71301
Ochsner Medical Center - Jefferson Highway- Site Number : 8400030 New Orleans Louisiana 70121
Johns Hopkins Hospital- Site Number : 8400015 Baltimore Maryland 21287
Massachusetts General Hospital- Site Number : 8400009 Boston Massachusetts 02114
Henry Ford Hospital- Site Number : 8400025 Detroit Michigan 48202
Michigan State University- Site Number : 8400038 East Lansing Michigan 48824
Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037 St Louis Missouri 63110
Profound Research- Site Number : 8400052 Las Vegas Nevada 89106
Hospital for Special Surgery - Site Number : 8400041 New York New York 10021
Columbia University Irving Medical Center- Site Number : 8400003 New York New York 10032
Raleigh Neurology Associates- Site Number : 8400043 Raleigh North Carolina 27607
University of Cincinnati Medical Center- Site Number : 8400020 Cincinnati Ohio 45219
University Hospitals Cleveland Medical Center- Site Number : 8400033 Cleveland Ohio 44106
Penn State Health Milton South Hershey Medical Center- Site Number : 8400042 Hershey Pennsylvania 17033
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022 Philadelphia Pennsylvania 19104
Austin Neuromuscular Center- Site Number : 8400040 Austin Texas 78756
UTHealth - The University of Texas Health Sciences Center at Houston- Site Number : 8400050 Houston Texas 77054
University of Vermont Medical Center- Site Number : 8400012 Burlington Vermont 05401
University of Virginia- Site Number : 8400023 Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06290128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06290128 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →